Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Founded by Adrian Hill and Sarah Gilbert in 2016, Vaccitech is backed by investors that include Sequoia Capital, GV, Oxford Sciences Innovation, Future Planet Capital, and Korea Investment Partners and is headquartered in Oxford.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Health Care, Medical, Therapeutics
FOUNDERS:
Adrian Hill, Sarah Gilbert
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
